Evidence for extracellular processing of pro-von Willebrand factor after infusion in animals with and without severe von Willebrand disease

Blood

Volumn 94, Issue 5, 1999, Pages 1637-1647

  Turecek, P L ^b   Pichler, L ^b   Auer, W ^b   Eder, G ^b   Varadi, K ^b   Mitterer, A ^b   Mundt, W ^b   Schlokat, U ^b   Dorner, F ^b   Drouet, L O ^b   Roussi, J ^b   Van Mourik, J A ^b   Schwarz, H P ^a  

^a BAXTER INNOVATIONS GMBH   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGAROSE; PROTEIN PRECURSOR; RECOMBINANT PROTEIN; RISTOCETIN; VON WILLEBRAND FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BABOON; CONTROLLED STUDY; DISEASE SEVERITY; DOG; DRUG INFUSION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DISRUPTION; GENE TARGETING; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOLECULAR SIZE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; SWINE; VON WILLEBRAND DISEASE;

EID: 13044311387     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.5.1637     Document Type: Article

References (53)

1. Wagner DD: Cell biology of von Willebrand factor. Annu Rev Cell Biol 6:217, 1990
2. Sadler JE: von Willebrand factor. J Biol Chem 266:22777, 1991
3. Sadler JE: Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 67:395, 1998
4. Montgomery RR, Coller BS: Von Willebrand disease, in Colman RW, Hirsh J, Marder VJ, Salzman EW (eds): Hemostasis and Thrombosis: Basic Principles and Clinical Practice (ed 3). Philadelphia, PA, Lippincott, 1994, p 134
5. Weiss HJ, Sussman II, Hoyer LW: Stabilization of factor VIII in plasma by the von Willebrand factor. J Clin Invest 60:390, 1977
6. Fay PJ, Kawai Y, Wagner DD, Ginsburg D, Bonthron D, Ohlsson-Wilhelm BM, Chavin SI, Abraham GN, Handin RI, Orkin SH, Montgomery RR, Marder VJ: Propolypeptide of von Willebrand factor circulates in blood and is identical to von Willebrand antigen II. Science 232:995, 1986
7. Ruggeri ZM, Ware J: The structure and function of von Willebrand factor. Thromb Haemost 67:594, 1992
8. Ruggeri ZM, Ware J: Von Willebrand factor. FASEB J 7:308, 1993
9. Vischer UM, Wagner DD: von Willebrand factor proteolytic processing and multimerization precede the formation of Weibel-Palade bodies. Blood 83:3536, 1994
10. Wise RJ, Barr PJ, Wong PA, Kieer MC, Brake AJ, Kaufman RJ: Expression of a human proprotein processing enzyme: Correct cleavage of the von Willebrand factor precursor at a paired basic amino acid site. Proc Natl Acad Sci USA 87:9378, 1990
11. van de Ven WJM, Voorberg J, Fontijn R, Pannekoek H, van den Ouweland AMW, van Duijnhoven HLP, Roebroek AJM, Soezem RJ: Furin is a subtilisin-like proprotein processing enzyme in higher eukaryotes. Mol Biol Rep 14:265, 1990
12. Hosaka M, Nagahama M, Kim WS, Watanabe T, Hatsuzawa K, Ikemizu J, Muarkami K, Nanakayama K: Arg-X-Lys/Arg-Arg motif as a signal for precursor cleavage catalyzed by furin within the constitutive secretory pathway. J Biol Chem 266:12127, 1991
13. Rehemtulla A, Kaufman RJ: Preferred sequence requirements for cleavage of pro-von Willebrand factor by propeptide-processing enzymes. Blood 79:2354, 1992
14. Wise RJ, Dorner AJ, Krane M, Pittman DD, Kaufman RJ: The role of von Willebrand factor multimer and propeptide cleavage in binding and stabilization of factor VIII. J Biol Chem 266:21948, 1991
15. Bendetowicz AV, Morris JA, Wise RJ, Gilbert GE, Kaufman RJ: Binding of factor VIII to von Willebrand factor is enabled by cleavage of the von Willebrand factor propeptide and enhanced by formation of disulfide-linked multimers. Blood 92:529, 1998
16. Leyte A, Verbeet MPh, Brodniewicz-Proba T, van Mourik J, Mertens K: The interaction between human blood-coagulation factor VIII and von Willebrand factor. Biochem J 257:679, 1989
17. Verweij CL, Hart M, Pannekoek H: Proteolytic cleavage of the precursor of von Willebrand factor is not essential for multimer formation. J Biol Chem 263:7921, 1988
18. Voorberg J, Fontijn R, van Mourik JA, Pannekoek H: Domains involved in multimer assembly of von Willebrand factor (vWF): Multimerization is independent of dimerization. EMBO J 9:797, 1990
19. Wagner DD, Fay PJ, Sporn LA, Sinha S, Lawrence SO, Marder VJ: Divergent fates of von Willebrand factor and its propolypeptide (von Willebrand antigen II) after secretion from endothelial cells. Proc Natl Acad Sci USA 84:1955, 1987
20. Vischer UM, Ingerslev J, Wollheim CB, Mestries J-C, Tsakris DA, Faefeli WE, Kruithof EKO: Acute von Willebrand factor secretion from the endothelium in vivo: Assessment through plasma propeptide (VWF:Ag II) levels. Thromb Haemost 77:387, 1997
21. Borchiellini A, Fijnvandraat K, ten Cate JW, Pajkrt D, van Deventer SJH, Pasterkamp G, Meijer-Huizinga F, Zwart Huinink L, Voorberg J, van Mourik JA: Quantitative analysis of von Willebrand factor propeptide release in vivo: Effect of experimental endotoxemia and administration of 1-deamino-8-d-arginine vasopressin in humans. Blood 88:2951, 1996
22. Wagner DD, Marder VJ: Biosynthesis of von Willebrand protein by human endothelial cells: Processing steps and their intracellular localization. J Cell Biol 99:2123, 1984
23. Sporn LA, Marder VJ, Wagner DD: Inducible secretion of large, biologically potent von Willebrand factor multimers. Cell 46:185, 1986
24. Fischer BE, Schlokat U, Mitterer A, Reiter M, Mundt W, Turecek PL, Schwarz HP, Dorner F: Structural analysis of recombinant von Willebrand factor produced at industrial scale fermentation of transformed CHO cells co-expressing recombinant furin. FEBS Lett 375: 259, 1995
25. Macfarlane DE, Stibbe J, Kirby EP, Zucker M, Grant RA and McPherson J: A method for assaying von Willebrand factor (ristocetin cofactor). Thromb Diath Haemorrh 34:306, 1975
26. Evans RM, Austen DEG: Assay of ristocetin co-factor using fixed platelets and a platelet counting technique. Br J Haematol 37:289, 1977
27. Austen DEG, Rhymes IL: A Laboratory Manual of Blood Coagulation. Oxford, UK, Blackwell Scientific, 1975
28. Fischer B, Schlokat U, Mitterer A, Den Bouwmeester R, Dorner F: Structural analysis of recombinant von Willebrand factor: Identification of hetero- and homo-dimers. FEBS Lett 351:345, 1994
29. Mejan O, Fert V, Delezay M, Delaage M, Cheballah R, Bourgois A: Immunopurification of human factor VIII/vWH complex from plasma. Thromb Haemost 59:364, 1998
30. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680, 1970
31. Smith BJ: SDS polyacrylamide gel electrophoresis of proteins, in Walker JM (ed): Methods in Molecular Biology - Volume 1: Proteins. Clifton, NJ, Humana, 1984, p 41
32. Turecek PL, Gritsch H, Pichler L, Auer W, Fischer B, Mitterer A, Mundt W, Schlokat U, Dorner F, Brinkman HJM, Van Mourik JA, Schwarz HP: In vivo characterization of recombinant von Willebrand factor in dogs with von Willebrand disease. Blood 90:3555, 1997
33. Markwell MAK: A new solid-state reagent to iodinate proteins: Conditions for the efficient labelling of antiserum. Anal Biochem 125:427, 1982
34. Roussi J, Turecek PL, Andre P, Bonneau M, Pignaud G, Bal dit Sollier C, Schlokat U, Dorner F, Schwarz HP, Drouet L: Effects of human recombinant, plasma-derived and porcine von Willebrand factor in pigs with severe von Willebrand disease. Blood Coagul Fibrinol 9:361, 1998
35. Schwarz HP, Turecek PL, Pichler L, Mitterer A, Mundt W, Dorner F, Roussi J, Drouet L: Recombinant von Willebrand factor. Thromb Haemost 78:571, 1997
36. Denis C, Methia N, Frenette PS, Rayburn H, Ulman-Cullere M, Hynes RO, Wagner DD: A mouse model of severe von Willebrand disease: Defects in hemostasis and thrombosis. Proc Natl Acad Sci USA 95:9524, 1998
37. Lee ML, Poon WY, Kingdon HS: A two-phase linear regression model for biologic half-life data. J Lab Clin Med 115:745, 1990
38. Dent JA, Galbusera M, Ruggeri ZM: Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit. J Clin Invest 88:774, 1991
39. Rieger M, Schwarz HP, Turecek PL, Dorner F, van Mourik JA, Mannhalter C: Identification of mutation in the canine von Willebrand factor gene causing type III von Willebrand disease. Thromb Haemost 80:332, 1998
40. Schlokat U, Fischer BE, Herlitschka S, Antoine G, Preininger A, Mohr G, Himmelspach M, Kistner O, Falkner FG, Dorner F: Production of highly homogeneous and structurally intact recombinant von Willebrand factor multimers by furin-mediated propeptide removal in vitro. Biotechnol Appl Biochem 24:257, 1996
41. Furlan M, Robles R, Affolter D, Meyer D, Baillod P: Triplet structure of von Willebrand factor reflects proteolytic degradation of high molecular weight multimers. Proc Natl Acad Sci USA 90:7503, 1993
42. Furlan M, Robles R, Lämmle B: Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 87:4223, 1996
43. Tsai HM: Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood 87:4235, 1996
44. Turecek PL, Furlan M, Lämmle B, Richter G, Gritsch H, Siekmann J, Schwarz HP: Cleavage of recombinant von Willebrand factor (vWF) by a vWF-depolymerizing protease. Blood 88:326a, 1996 (abstr, suppl 1)
45. De Romeuf C, Mazurier C: Comparison between von Willebrand factor (VWF) and VWF antigen II in normal individuals and patients with von Willebrand disease. Thromb Haemost 80:37, 1998
46. McCarroll DR, Ruggeri ZM, Montgomery RR: The effect of DDAVP on plasma levels of von Willebrand antigen II in normal individuals and patients with von Willebrand's disease. Blood 63:532, 1984
47. van Genderen PJJ, Boertjes RC, van Mourik JA: Quantitative analysis of von Willebrand factor and its propeptide in plasma in acquired von Willebrand syndrome. Thromb Haemost 80:495, 1998
48. Verweij CL, Hart M, Pannekoek H: Expression of variant von Willebrand factor (vWF) cDNA in heterologous cells: Requirement of the pro-polypeptide in vWF multimer formation. EMBO J 6:2885, 1987
49. Wise RJ, Pittman DD, Handin RI, Kaufman RJ, Orkin SH: The propeptide of von Willebrand factor independently mediates the assembly of von Willebrand multimers. Cell 52:229, 1988
50. Mayades TN, Wagner DD: Vicinal cysteines in the prosequence play a role in von Willebrand factor multimer assembly. Proc Natl Acad Sci USA 89:3531, 1992
51. Takagi J, Aoyama T, Ueki S, Ohba H, Saito Y, Lorand L: Identification of factor-XIIIa-reactive glutaminyl residues in the propolypeptide of bovine von Willebrand factor. Eur J Biochem 232:773, 1995
52. Takagi J, Sekiya F, Kasahara K, Inada Y, Saito Y: Inhibition of platelet-collagen interaction by propolypeptide of von Willebrand factor. J Biol Chem 264:6017, 1989
53. Isobe T, Hisaoka T, Shimizu A, Okuno M, Aimoto S, Takada Y, Saito Y, Takagi J: Propolypeptide of von Willebrand factor is a novel ligand for very late antigen-4 integrin. J Biol Chem 272:8447, 1997